Wiviott, Stephen D

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 4.

Journal Article

McClung, Michael R; O'Donoghue, Michelle L; Papapoulos, Socrates E; Bone, Henry; Langdahl, Bente; Saag, Kenneth G; Reid, Ian R; Kiel, Douglas P; Cavallari, Ilaria; Bonaca, Marc P; Wiviott, Stephen D; de Villiers, Tobias; Ling, Xu; Lippuner, Kurt; Nakamura, Toshitaka; Reginster, Jean-Yves; Rodriguez-Portales, Jose Adolfo; Roux, Christian; Zanchetta, José; Zerbini, Cristiano A F; ... (2019). Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. The lancet. Diabetes & endocrinology, 7(12), pp. 899-911. Elsevier 10.1016/S2213-8587(19)30346-8

Mauri, Laura; Elmariah, Sammy; Yeh, Robert W; Cutlip, Donald E; Steg, P Gabriel; Windecker, Stephan; Wiviott, Stephen D; Cohen, David J; Massaro, Joseph M; D'Agostino, Ralph B; Braunwald, Eugene; Kereiakes, Dean J (2016). Causes of late mortality with dual antiplatelet therapy after coronary stents. European Heart Journal, 37(4), pp. 378-385. Oxford University Press 10.1093/eurheartj/ehv614

Yeh, Robert W; Kereiakes, Dean J; Steg, Philippe Gabriel; Windecker, Stephan; Rinaldi, Michael J; Gershlick, Anthony H; Cutlip, Donald E; Cohen, David J; Tanguay, Jean-Francois; Jacobs, Alice; Wiviott, Stephen D; Massaro, Joseph M; Iancu, Adrian C; Mauri, Laura (2015). Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. Journal of the American College of Cardiology, 65(20), pp. 2211-2221. Elsevier 10.1016/j.jacc.2015.03.003

Mauri, Laura; Kereiakes, Dean J; Yeh, Robert W; Driscoll-Shempp, Priscilla; Cutlip, Donald E; Steg, P Gabriel; Normand, Sharon-Lise T; Braunwald, Eugene; Wiviott, Stephen D; Cohen, David J; Holmes, David R; Krucoff, Mitchell W; Hermiller, James; Dauerman, Harold L; Simon, Daniel I; Kandzari, David E; Garratt, Kirk N; Lee, David P; Pow, Thomas K; Ver Lee, Peter; ... (2014). Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. New England journal of medicine NEJM, 371(23), pp. 2155-2166. Massachusetts Medical Society MMS 10.1056/NEJMoa1409312

This list was generated on Fri Mar 29 13:12:11 2024 CET.
Provide Feedback